Scientific Program, Thursday 12 September

12.30  Welcome and opening remarks 
Eva Åkesson, Vice-chancellor, Uppsala University, Sweden
Stellan Sandler, Vice-rector, Uppsala University, Sweden

12.40  150-year anniversary of the discovery of pancreatic islets - New horizons
Chair Anders Tengholm, Uppsala University, Sweden

Insights from combined functional and transcriptomic profiling of human islet cells           
Patrick MacDonald, University of Alberta, Canada

GABA signalling in pancreatic islets
Bryndis Birnir, Uppsala University, Sweden

Organelle dynamics in beta-cells
Olof Idevall, Uppsala University, Sweden

14.00  Coffee break

14.30  Session cont.

New insights into the innervation of the pancreatic islet
Alejandro Caicedo, University of Miami, Miller School of Med, USA

Imaging local immune regulation in the pancreas
Gustaf Christoffersson, Uppsala University, Sweden

In vivo drug discovery to stimulate beta-cell regeneration
Olov Andersson, Karolinska Institutet, Sweden

Enteroendocrine cells and glucose homeostasis
Frank Reimann, University of Cambridge, United Kingdom

17.00  Göran Gustafsson Lecture in Medicine 2019

Anders Malmberg, Deputy vice-chancellor, Uppsala University

Brain neuronal circuits controlling glucose homeostasis and feeding behavior
Bernard Thorens, University of Lausanne, Switzerland

18.00  Scientific poster exhibition with refreshments

Back to top

Scientific Program, Friday 13 September

9.00   Type 2 diabetes – New paradigms in pathobiology and treatment
Chair Jan Eriksson, Uppsala University, Sweden

Stratification of type 2 diabetes patients: will it enable precision medicine?
Jan Eriksson, Uppsala University, Sweden

Non-alcoholic fatty liver disease:insights from cellular and animal models
Angela M. Valverde, Institute of Biomedicine Alberto Sols (CSIC) and CIBERDEM, Madrid, Spain

Image and CRISPR-based screens in zebrafish larvae to improve our understanding of diabetes aetiology
Marcel den Hoed, Uppsala University, Sweden

10.20  Coffee break

10.50  Session cont.

Incretin hormones – basis for new treatment era
Tina Vilsböll, University of Copenhagen, Denmark

Will SGLT2 inhibitors change the diabetes and cardiovascular landscape?
John Wilding, University of Liverpool, United Kingdom

11.50  Lunch

13.00  Technical applications for the advances of diabetes
Chair Per-Ola Carlsson, Uppsala University, Sweden

Oxygenated macrocapsules for pancreatic islet transplantation
Klearchos Papas, University of Arizona, USA

CRISPR Cas9 technology for human pluripotent reprogramming and the understanding of human beta-cell disease
Diego Balboa, Helsinki University, Finland

Novel tracers for imaging of the pancreas and their beta-cells by PET
Olof Eriksson, Uppsala University, Sweden

Closed loop technology
Roman Hovorka, University of Cambridge, United Kingdom

Imiomics and machine learning in whole-body imaging studies of diabetes
Robin Strand, Uppsala University

15.10  Coffee break

15.40  How do we form societies preventing diabetes?
Chair Tove Fall, Uppsala University, Sweden

Cities changing diabetes
Anna-Maria Volkmann, University College London, United Kingdom

Can we feed a future population of 10 billion people a healthy diet within planetary boundaries?
Brent Loken, Stockholm University, Sweden: EAT foundation

Environmental pollutants and diabetes
Duk-Hee Lee, Kyungpook National University, Korea

Circadian rhythms, shift work and diabetes
Jonathan Cedernaes, Uppsala University, Sweden

Back to top